Cargando…

Iodine-131: An Effective Method for Treating Lymph Node Metastases of Differentiated Thyroid Cancer

BACKGROUND: The aim of this study was to assess the efficacy of radioactive iodine-131 ((131)I) therapy for lymph node metastasis of differentiated thyroid cancer (DTC) and to identify influential factors using univariate and multivariate analyses to determine if identified factors influence the eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Ying, Pan, Ming-zhi, Huang, Jian-min, Xie, Peng, Zhang, Fang, Wei, Ling-ge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2016
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181522/ https://www.ncbi.nlm.nih.gov/pubmed/27974741 http://dx.doi.org/10.12659/MSM.899028

Ejemplares similares

Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine
por: Yun, Canhua, et al.
Publicado: (2021)

Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014)

Radioactive Body Burden Measurements in (131)Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body (131)Iodine Clearance
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2014)

Analysis of the clinical factors affecting excellent response of Iodine-131 treatment for pulmonary metastases from differentiated thyroid cancer
por: Wu, Xin-Yu, et al.
Publicado: (2023)

Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy
por: Salvatore, Barbara, et al.
Publicado: (2017)

Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma
por: Fan, Weina, et al.
Publicado: (2018)

Lymph Node Thyroglobulin Measurement in Diagnosis of Neck Metastases of Differentiated Thyroid Carcinoma
por: Giovanella, Luca, et al.
Publicado: (2011)

Leukaemias and cancers following iodine-131 administration for thyroid cancer.
por: de Vathaire, F., et al.
Publicado: (1997)

Iodine-131 and Thyroid Function: Ostroumova et al. Respond
por: Ostroumova, Evgenia, et al.
Publicado: (2014)

Role and Extent of Neck Dissection for Neck Lymph Node Metastases in Differentiated Thyroid Cancers
por: Aygun, Nurcihan, et al.
Publicado: (2021)

The Prediction of Metastases of Lateral Cervical Lymph Node in Medullary Thyroid Carcinoma
por: Zhou, Tian-Han, et al.
Publicado: (2021)

Risk factors for level V lymph node metastases in solitary papillary thyroid carcinoma with clinically lateral lymph node metastases
por: Yang, Jing, et al.
Publicado: (2016)

Effectiveness and Safety of Levothyroxine Tablets Combined with Iodine-131 in the Treatment of Thyroid Cancer
por: Bai, Yang, et al.
Publicado: (2022)

Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer
por: Lee, Chang-Hee, et al.
Publicado: (2018)

BRAF V600E and lymph node metastases in papillary thyroid cancer
por: Chen, Pan, et al.
Publicado: (2020)

Lymph Node Metastases Identified at the Post-Ablation 131I SPECT/CT Scan Is a Prognostic Factor of Intermediate-Risk Papillary Thyroid Cancer
por: Jia, Xi, et al.
Publicado: (2022)

Effect of (131)I Therapy on Complete Blood Count in Patients with Differentiated Thyroid Cancer
por: Rui, Zhongying, et al.
Publicado: (2021)

Resveratrol Sensitizes Selectively Thyroid Cancer Cell to 131-Iodine Toxicity
por: Hosseinimehr, Seyed Jalal, et al.
Publicado: (2014)

Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review
por: Attard, Andrea, et al.
Publicado: (2019)

Single‐Fiber Laser Ablation in Treating Selected Metastatic Lymph Nodes of Papillary Thyroid Carcinoma and Benign Cold Thyroid Nodules—Preliminary Results
por: Guo, YuQing, et al.
Publicado: (2019)

Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up
por: Hatipoğlu, Filiz, et al.
Publicado: (2016)

DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131)
por: Prpić, Marin, et al.
Publicado: (2019)

Do radioiodine-avid lymph nodes from differentiated thyroid cancer on the initial posttherapy scan need repeated (131)I therapy?
por: Jiang, Yongji, et al.
Publicado: (2023)

Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment
por: Klain, Michele, et al.
Publicado: (2019)

Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma
por: Zhao, Hengqiang, et al.
Publicado: (2023)

Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy
por: Yu, Feng, et al.
Publicado: (2021)

Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto's thyroiditis
por: Konturek, Aleksander, et al.
Publicado: (2014)

Lymph Node Metastases Papillary Thyroid Carcinoma and their Importance in Recurrence of Disease
por: Maksimovic, Sinisa, et al.
Publicado: (2018)

Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma
por: Wu, Xin, et al.
Publicado: (2020)

Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size
por: Zhang, Xiaojun, et al.
Publicado: (2021)

Lymph Node Dissection for Differentiated Thyroid Cancer
por: Mizrachi, Aviram, et al.
Publicado: (2017)

Rare case of axillary lymph node metastasis in papillary thyroid carcinoma detected using Iodine-131 whole-body scintigraphy and single-photon emission computed tomography/computed tomography
por: Kamaleshwaran, Koramadai Karuppusamy, et al.
Publicado: (2015)

Prediction of cervical lymph node metastases in papillary thyroid microcarcinoma by sonographic features of the primary site
por: Wei, Xi, et al.
Publicado: (2019)

Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
por: Ravichandran, R, et al.
Publicado: (2010)

(131)I thyroid activity and committed dose assessment among family members of patients treated with radioactive iodine
por: Brudecki, K., et al.
Publicado: (2020)

An Interesting Case of Retropharyngeal Lymph Nodal Metastases in a Case of Iodine-Refractory Thyroid Cancer
por: Harisankar, Chidambaram Natrajan Balasubramanian, et al.
Publicado: (2018)

Metastatic lymph node characteristics as predictors of recurrence/persistence in the neck and distant metastases in differentiated thyroid cancer
por: Barbosa, Mayara Peres, et al.
Publicado: (2017)

Genetic alterations of differentiated thyroid carcinoma in iodine‐rich and iodine‐deficient countries
por: Vuong, Huy Gia, et al.
Publicado: (2016)

Human Papillomavirus Status in Primary Lesions and Pelvic Lymph Nodes and Its Prognostic Value in Cervical Cancer Patients with Lymph Node Metastases
por: Chen, Peng, et al.
Publicado: (2019)

Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases
por: Al-Qahtani, Khalid Hussain, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6klaafna8kh42asllcess9qkur